SpineGuard SA (ALSGD.PA)

EUR 0.23

(-1.09%)

EBITDA Summary of SpineGuard SA

  • SpineGuard SA's latest annual EBITDA in 2023 was -3.49 Million EUR , down -112.7% from previous year.
  • SpineGuard SA's latest quarterly EBITDA in 2024 Q2 was -1.54 Million EUR , down 0.0% from previous quarter.
  • SpineGuard SA reported an annual EBITDA of -1.26 Million EUR in 2022, down -41.22% from previous year.
  • SpineGuard SA reported an annual EBITDA of -812.46 Thousand EUR in 2021, down -35.48% from previous year.
  • SpineGuard SA reported a quarterly EBITDA of -1.89 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • SpineGuard SA reported a quarterly EBITDA of N/A for 2023 FY, down -112.7% from previous quarter.

Annual EBITDA Chart of SpineGuard SA (2023 - 2011)

Historical Annual EBITDA of SpineGuard SA (2023 - 2011)

Year EBITDA EBITDA Growth
2023 -3.49 Million EUR -112.7%
2022 -1.26 Million EUR -41.22%
2021 -812.46 Thousand EUR -35.48%
2020 -1.59 Million EUR -284.63%
2019 61.14 Thousand EUR 78.47%
2018 -959.35 Thousand EUR 60.27%
2017 -3.16 Million EUR 31.17%
2016 -3.44 Million EUR 9.45%
2015 -3.62 Million EUR 11.68%
2014 -4.21 Million EUR -44.35%
2013 -3.03 Million EUR 0.73%
2012 -3.03 Million EUR -25.04%
2011 -2.44 Million EUR 0.0%

Peer EBITDA Comparison of SpineGuard SA

Name EBITDA EBITDA Difference
Affluent Medical SA -13.34 Million EUR 73.793%
Bluelinea Société Anonyme -323.98 EUR -1079232.058%
Carmat SA -50.45 Million EUR 93.069%
Diagnostic Medical Systems S.A. -7.05 Million EUR 50.449%
Euromedis Groupe -4.43 Million EUR 21.157%
Eurobio Scientific Société anonyme 18.98 Million EUR 118.418%
Ikonisys S.A. -2.34 Million EUR -48.958%
Implanet S.A. -5.07 Million EUR 31.124%
Median Technologies SA -19.58 Million EUR 82.145%
Theraclion SA -4.48 Million EUR 22.072%
Euroapi S.A. -155.39 Million EUR 97.75%
Guerbet SA 98.83 Million EUR 103.538%
Ion Beam Applications SA 12.53 Million EUR 127.908%
Koninklijke Philips N.V. 1.04 Billion EUR 100.336%
Sequana Medical NV -29.13 Million EUR 87.999%